RDY
Dr. Reddy's Laboratories Ltd. Earnings
$15.07
Earnings Summary
Revenue | $85060Mn |
Net Profits | $15938Mn |
Net Profit Margins | 18.74% |
PE Ratio | 18.84 |
Dr. Reddy's Laboratories Ltd.’s revenue jumped 20.09% since last year same period to $85060Mn in the Q1 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 1.76% jump in its revenue since last 3-months.
Dr. Reddy's Laboratories Ltd.’s net profit jumped 21.94% since last year same period to $15938Mn in the Q1 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 12.77% jump in its net profits since last 3-months.
Dr. Reddy's Laboratories Ltd.’s net profit margin jumped 1.54% since last year same period to 18.74% in the Q1 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 10.82% jump in its net profit margins since last 3-months.
Dr. Reddy's Laboratories Ltd.’s price-to-earnings ratio after this Q1 2025 earnings stands at 18.84.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.2 |
EPS Estimate Current Year | 0.2 |
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current quarter stand at 0.2 - a -2.52% fall from last quarter’s estimates.
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current year stand at 0.2.
Key Ratios
Earning Per Share (EPS) | 0 |
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2025. This indicates that the Dr. Reddy's Laboratories Ltd. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-07-23 | 0.2 | 0 | -100% |
2025-06-06 | 0.21 | 0.22 | 4.76% |
